NDC 50242-922 – Hemlibra
Emicizumab 105 mg/.7mL · Injection, Solution · Subcutaneous
Product NDC50242-922
Product details
- Brand name
- Hemlibra
- Generic name
- Emicizumab
- Labeler
- Genentech, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761083
- Marketed since
- November 16, 2017
- Listing expires
- December 31, 2026
Active ingredients
- Emicizumab 105 mg/.7mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50242-922-01 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-922-01) / .7 mL in 1 VIAL, SINGLE-USE | Nov 16, 2017 |
Other Hemlibra products
- 50242-920 Emicizumab 30 mg/mL · Injection, Solution · Genentech, Inc.
- 50242-921 Emicizumab 60 mg/.4mL · Injection, Solution · Genentech, Inc.
- 50242-923 Emicizumab 150 mg/mL · Injection, Solution · Genentech, Inc.
- 50242-927 Emicizumab 12 mg/.4mL · Injection, Solution · Genentech, Inc.
- 50242-930 Emicizumab 300 mg/2mL · Injection, Solution · Genentech, Inc.